Pacific Biosciences of California, Inc. (PACB) vs Tactile Systems Technology, Inc. (TCMD)
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
- Tactile Systems Technology, Inc. TCMD 22.52 −3.31%
Pacific Biosciences of California, Inc. and Tactile Systems Technology, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. is the larger, with a market value of $609.2M against $527.6M — 1.2× the size. Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; Tactile Systems Technology, Inc. trades at 20.5×. Tactile Systems Technology, Inc. grew revenue faster over the last twelve months: 17.2% against 2.02%. Tactile Systems Technology, Inc. has the higher net margin (7.10% vs −82.5%) and the higher return on invested capital (15.7% vs −22.2%). Across the 17 metrics below, Tactile Systems Technology, Inc. leads on 14 and Pacific Biosciences of California, Inc. on 3.
Valuation
Profitability
| Metric | PACB | TCMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 36.38% | 76.78% | 56.01% |
| Operating margin | (83.53%) | 10.00% | (15.03%) |
| Net margin | (82.49%) | 7.10% | (20.40%) |
| Free cash flow margin | (50.53%) | 7.61% | (7.24%) |
| Return on equity | (929.31%) | 11.88% | (15.32%) |
| Return on assets | (16.66%) | 9.00% | (19.72%) |
| Return on invested capital | (22.22%) | 15.74% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack